The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens
Open accessAbstract
The distribution of strains producing metallo-beta-lactamase among 105 strains of Serratia marcescens was investigated. All of these strains were isolated in seven general hospitals located in Aichi Prefecture, Japan, from April to May 1993. Southern hybridization analysis suggested that four S. marcescens strains, AK9373, AK9374, AK9385, and AK9391, had a metallo-beta-lactamase genes similar to the blaIMP gene found by our laboratory (E. Osano, Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato, Antimicrob. Agents Chemother. 38:71-78, 1994), and these four strains showed resistance to carbapenems as well as to the other broad-spectrum beta-lactams. In particular, strains AK9373, AK9374, and AK9391 showed an extraordinarily high-level resistance to imipenem (MICs, > or = 64 micrograms/ml), whereas strain AK9385 demonstrated moderate imipenem resistance (MIC, 8 micrograms/ml). The imipenem resistance of AK9373 was transferred to Escherichia coli CSH2 by conjugation with a frequency of 10(-5). The DNA probe of the blaIMP gene hybridized to a large plasmid (approximately 120 kb) transferred into the E. coli transconjugant as well as to the large plasmids harbored by AK9373. On the other hand, although we failed in the conjugational transfer of imipenem resistance from strains AK9374, AK9385, and AK9391 to E. coli CSH2, imipenem resistance was transferred from these strains to E. coli HB101 by transformation. A plasmid (approximately 25 kb) was observed in each transformant which acquired imipenem resistance. The amino acid sequence at the N terminus of the enzyme purified from strain AK9373 was identical to that of the metallo-beta-lactamase IMP-1. In contrast, strains ES9348, AK9386, and AK93101, which were moderately resistant to imipenem (MICs, > or = 4 to < or = 8 micrograms/ml), had no detectable blaIMP gene. As a conclusion, 19% of clinically isolated S. marcescens strains in Aichi Prefecture, Japan, in 1993 were resistant to imipenem (MICs, > or = 2 micrograms/ml), and strains which showed high-level imipenem resistance because of acquisition of a plasmid-mediated blaIMP-like metallo-beta-lactamase gene had already proliferated as nosocomial infections, at least in a general hospital.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
Rapid procedure for detection and isolation of large and small plasmids
Kado, C. I., & Liu, S. T. (1981) · Journal of Bacteriology · doi:10.1128/jb.145.3.1365-1373.1981 · Cited by 2,809
Jarlier, V., Nicolas, M.-H., Fournier, G., & Philippon, A. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.867 · Cited by 1,559
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 700
Takeshita, S., Sato, M., Toba, M., Masahashi, W., & Hashimoto-Gotoh, T. (1987) · Gene · doi:10.1016/0378-1119(87)90365-9 · Cited by 695
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Self-citationPapanicolaou, G. A., Medeiros, A. A., & Jacoby, G. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2200 · Cited by 313
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa Infections
Quinn, J. P., Dudek, E. J., DiVincenzo, C. A., Lucks, D. A., & Lerner, S. A. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.2.289 · Cited by 276
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., Lee, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 274
Vartivarian, S., Anaissie, E., Bodey, G., Sprigg, H., & Rolston, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.624 · Cited by 199
Naas, T., Vandel, L., Sougakoff, W., Livermore, D. M., & Nordmann, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1262 · Cited by 184
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Seeberg, A., Tolxdorff-Neutzling, R., & Wiedemann, B. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.6.918 · Cited by 156
Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins
Matsumoto, Y., Ikeda, F., Kamimura, T., Yokota, Y., & Mine, Y. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1243 · Cited by 145
Arakawa, Y., Ohta, M., Kido, N., Mori, M., Ito, H., Komatsu, T., Fujii, Y., & Kato, N. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.63 · Cited by 123
Self-citationArakawa, Y., Ohta, M., Kido, N., Fujii, Y., Komatsu, T., & Kato, N. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80014-x · Cited by 80
Self-citationHorii, T., Arakawa, Y., Ohta, M., Sugiyama, T., Wacharotayankun, R., Ito, H., & Kato, N. (1994) · Gene · doi:10.1016/0378-1119(94)90529-0 · Cited by 58
Self-citationDomains involved in osmoregulation of the ompF gene in Escherichia coli
Inokuchi, K., Itoh, M. N., & Mizushima, S.-I. (1985) · Journal of Bacteriology · doi:10.1128/jb.164.2.585-590.1985 · Cited by 24
Malouin, F., Campbell, G., Halpenny, M., Becker, G. W., & Parr, T. R. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1247-1253.1990 · Cited by 22
Cited by
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038
Metadata
- Authors
- Ito, H., Arakawa, Y., Ohsuka, S., Wacharotayankun, R., Kato, N., & Ohta, M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1995-04
- Volume
- 39
- Issue
- 4
- Pages
- 824-829
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2023230750
- Cited by
- 266
- References
- 23
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.